Immunosuppressive Combination and Its Use in the Treatment or Prophylaxis of Insulin-producing Cell Graft Rejection

• 收藏
• 分享

专利权人:

Philip Lake

发明人:

Philip Lake,Claudy Mullon

申请号：

US14098179

公开号：

US20140093502A1

申请日:

2013.12.05

申请国别(地区):

US

年份:

2014

代理人:

摘要：

A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/